Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin–reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighted the important contributions of various cellular and soluble participants in the vaso-occlusive cascade. The role of these elements and the opportunities for therapeutic intervention are summarized in this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vaso-occlusion, or blood vessel occlusion, leading to ischemia is the predominant pathophysiology responsible for acute systemic painful vaso-occlusive crisis (VOC) and the requirement for emergency medical care by SCD patients (13).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [13]
Citations
Cites
Circadian control of the immune system
Scheiermann, C., Kunisaki, Y., & Frenette, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3386 · Cited by 1,135 · cited 1×
“Diurnal differences of admission to the hospital of SCD patients in VOC crisis have been reported, although the gradual onset of VOC crisis renders circadian influences difficult to discern.(10)”
BackgroundSelf-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Adrenergic Nerves Govern Circadian Leukocyte Recruitment to Tissues
Scheiermann, C., Kunisaki, Y., Lucas, D., Chow, A., Jang, J.-E., Zhang, D., Hashimoto, D., Merad, M., & Frenette, P. S. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.021 · Cited by 516 · cited 2×
“response.(9) Adrenergic control of leukocyte trafficking produces higher densities of adherent leukocytes in venules at nighttime in mice.”
BackgroundSelf-citationPrimary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 489 · cited 1×
“Both endothelial selectins, P-selectin and E-selectin, have been suggested to participate in VOC.(5,6) An anti–P-selectin aptamer in SCD mice resulted in a decreased adhesion of SS-RBCs, increased microvascular flow velocities, and reduced adhesion of the leukocyte to the endothelium, underscoring the importance of P-…”
BackgroundSelf-citationShappell, S. B., Toman, C., Anderson, D. C., Taylor, A. A., Entman, M. L., & Smith, C. W. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2702 · Cited by 402 · cited 1×
“E-selectin signaling can trigger “inside-out” aMb2 activation at the leading edge of the neutrophils, whereas the engagement of platelets by activated aMb2 can trigger “outside-in” signaling in neutrophils, leading to production of reactive oxygen species.(19) Although no significant platelet accumulation has been obs…”
BackgroundHidalgo, A., Chang, J., Jang, J.-E., Peired, A. J., Chiang, E. Y., & Frenette, P. S. (2009) · Nature Medicine · doi:10.1038/nm.1939 · Cited by 358 · cited 1×
“Although both P-selectin and E-selectin are important for adhesion of leukocytes to the endothelium, E-selectin on the endothelium appears to be crucial for generating a secondary wave of activating signals, which produces a polarized expression of activated aMb2 integrin (also known as CD11b/CD18 or Mac-1) at the lea…”
BackgroundSelf-citationSaunthararajah, Y., Hillery, C. A., Lavelle, D., Molokie, R., Dorn, L., Bressler, L., Gavazova, S., Chen, Y.-H., Hoffman, R., & DeSimone, J. (2003) · Blood · doi:10.1182/blood-2003-05-1738 · Cited by 277
Sickle cell vaso-occlusion: multistep and multicellular paradigm
Frenette, P. S. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200203000-00003 · Cited by 274 · cited 1×
“Hofstra et al first reported that neutrophils could bind to SSRBCs in vitro.(17) In contrast to the previously described interaction with the endothelium, the dense cell fractions that included irreversibly sickled RBCs appeared to be the most adherent to neutrophils.”
ResultSelf-citationAbdulmalik, O., Safo, M. K., Chen, Q., Yang, J., Brugnara, C., Ohene‐Frempong, K., Abraham, D. J., & Asakura, T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05332.x · Cited by 243
Cited by
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611770 · Cited by 914
Neutrophil ageing is regulated by the microbiome
Zhang, D., Chen, G., Manwani, D., Mortha, A., Xu, C., Faith, J. J., Burk, R. D., Kunisaki, Y., Jang, J.-E., Scheiermann, C., et al. (2015) · Nature · doi:10.1038/nature15367 · Cited by 839
Self-citationPathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Self-citationSickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Inusa, B., Hsu, L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K., & Atoyebi, W. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5020020 · Cited by 313
Metadata
- Authors
- Manwani, D., & Frenette, P. S.
- Affiliations
- Departments of Pediatrics,
- Albert Einstein College of Medicine (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-12-05
- Volume
- 122
- Issue
- 24
- Pages
- 3892-3898
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3854110
- OpenAlex
- W2019381418
- Cited by
- 428
- References
- 56
- Citations by year
- 2026: 30 · 2025: 33 · 2024: 41 · 2023: 31 · 2022: 38 · 2021: 28 · 2020: 51 · 2019: 50 · 2018: 37 · 2017: 26 · 2016: 24 · 2015: 20 · 2014: 17
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL116340, R01HL069438, R01HL097819)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056638)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sickle cell disease, vascular occlusion, pathophysiology, hydroxyurea, fetal hemoglobin reactivation, targeted therapy, soluble factors, cellular factors
- MeSH terms
- Anemia, Sickle Cell, Antisickling Agents, Cell Adhesion, Endothelium, Vascular, Humans, Hydroxyurea, Models, Biological, Neutrophils, Vascular Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. https://app.cochat.ai/papers/10.1182/blood-2013-05-498311
- The paper
- Manwani, D., & Frenette, P. S. (2013). Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood. https://doi.org/10.1182/blood-2013-05-498311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.